Skip to content

Clinical trials

Phase 3 Anemia, Sickle Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Sickle Cell Phase: Phase 3 Clear all

90 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20041
20053
200610
20072
20081
20091
20104
20113
20121
20133
20141
20155
20165
20172
20183
20197
20205
20215
20228
20232
20241
20255
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Terminated27
Recruiting11
Active, not recruiting5
Unknown status5
Withdrawn3
Not yet recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer9
Assistance Publique - Hôpitaux de Paris5
National Heart, Lung, and Blood Institute (NHLBI)4
Vertex Pharmaceuticals Incorporated4
Actelion3
Children's Hospital Medical Center, Cincinnati3
Mast Therapeutics, Inc.3
Novartis Pharmaceuticals3
AstraZeneca2
Augusta University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Sickle Cell90
Vaso-Occlusive Crises21
Hematologic Diseases16
Hemoglobinopathies7
Acute Chest Syndrome5
Pain5
Sickle Cell Trait5
Stroke5
Agnosia4
Genetic Diseases, Inborn4

Trials

Showing 26 to 50 of 90. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.